Onsero Therapeutics
Founded in early 2021 through partnerships with leading US academic institutions, Onsero Therapeutics is a discovery stage biopharmaceutical company that combines a deep understanding of biology and neurocircuitry of the brain with advanced chemistry to develop and discover new therapies. Onsero Therapeutics’ team is working tirelessly to advance their understanding of a broad range of psychiatric and neurological diseases in an effort to bring real progress and new treatment options to millions of people affected by complex mental illnesses.
Visit Site